Patents

US 12247213 B2: Treatment of mucopolysaccharidosis IVA

Granted
2025-03-11
Filed
2019-07-26 application 17263049
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are gene therapy methods for the treatment of mucopolysaccharidosis type IVA (MPS IVA) involving the use of recombinant adeno-associated viruses (rAAVs) to deliver human N-acetylgalactosamine-6-sulfate sulfatase (hGALNS) to the bone of a human subject diagnosed with MPS IVA. Also provided herein are rAAVs that can be used in the gene therapy methods and methods of making such rAAVs.

Source: PVGPATDIS, file of 2026-04-10 (ipg250311.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Nemours Foundation 18 patentsUS company or organizationWilmington, DETHE NEMOURS FOUNDATION State business registration EXACT high confidence: identical full name and state
THE NEMOURS FOUNDATION Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10
REGENXBIO INC. 15 patentsUS company or organizationRockville, MDREGENXBIO Inc. Form D issuer EXACT high confidence: identical full name and state
REGENXBIO INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Shunji TomatsuWilmington, DE12PVGPATDIS, file of 2026-04-10
Kazuki SawamotoTokyo, JP1PVGPATDIS, file of 2026-04-10
Subha Karumuthil-MelethilGermantown, MD1PVGPATDIS, file of 2026-04-10
Olivier DanosPrinceton, NJ12PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/86PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K48/0058PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P19/00PVGPATDIS, file of 2026-04-10
A01KAnimal husbandry; aviculture; apiculture; pisciculture; fishing; rearing or breeding animals, not otherwise provided for; new breeds of animalsA01K2217/054PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K2319/00PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y301/06004PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-09-21Assignment
Assignment of assignor's interest
TOMATSU, SHUNJI signed 2021-04-20
SAWAMOTO, KAZUKI signed 2021-04-21
THE NEMOURS FOUNDATION WILMINGTON, DE57541/837ECORSEXC, file of 2026-09-25
2021-04-20Assignment
Assignment of assignor's interest
DANOS, OLIVIER signed 2021-03-17
KARUMUTHIL-MELETHIL, SUBHA signed 2021-03-29
REGENXBIO INC. ROCKVILLE, MD55966/982ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.